Published in Biotechniques on January 01, 1998
Multiplex PCR: optimization and application in diagnostic virology. Clin Microbiol Rev (2000) 4.33
Census of the bacterial community of the gypsy moth larval midgut by using culturing and culture-independent methods. Appl Environ Microbiol (2004) 2.55
A new class of homogeneous nucleic acid probes based on specific displacement hybridization. Nucleic Acids Res (2002) 1.76
Rapid identification and differentiation of Bartonella species using a single-step PCR assay. J Clin Microbiol (2000) 1.68
Improved multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans, Bacteroides forsythus, and Porphyromonas gingivalis. J Clin Microbiol (1999) 1.34
Clinically applicable multiplex PCR for four middle ear pathogens. J Clin Microbiol (2000) 1.32
Identification of alternative splicing and negative splicing activity of a nonsegmented negative-strand RNA virus, Borna disease virus. Proc Natl Acad Sci U S A (2000) 0.95
Multiplex PCR for screening of microdeletions on the Y chromosome. J Assist Reprod Genet (2001) 0.92
RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers. BMC Biotechnol (2011) 0.90
Is the perceived association between Chlamydia pneumoniae and vascular diseases biased by methodology? J Clin Microbiol (2004) 0.84
Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma. Br J Cancer (2008) 0.82
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature (2002) 19.35
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Massive gene decay in the leprosy bacillus. Nature (2001) 11.98
New insights to the MLL recombinome of acute leukemias. Leukemia (2009) 4.07
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia (2009) 2.78
Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature (2002) 2.59
The MLL recombinome of acute leukemias in 2013. Leukemia (2013) 2.55
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30
Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol (1999) 2.25
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Leukemia (2000) 2.21
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood (1994) 2.11
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood (1995) 2.00
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood (2000) 1.93
Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res (2001) 1.75
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. J Clin Oncol (1995) 1.72
Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis. Pediatr Hematol Oncol (1999) 1.67
Biomarker evidence for a major preservation pathway of sedimentary organic carbon. Science (2006) 1.66
Differentiation of species and strains among filamentous fungi by DNA fingerprinting. Curr Genet (1991) 1.65
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia (2005) 1.60
Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol (1993) 1.57
Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcoma. Pediatr Blood Cancer (2006) 1.51
Host response to mycobacterial infection in the alcoholic rat. Gastroenterology (1990) 1.44
Concentration dependency of the BAC/BrAC (blood alcohol concentration/breath alcohol concentration) conversion factor during the linear elimination phase. Int J Legal Med (2003) 1.43
Fosfomycin does not reduce cytostatic activity of cis-platinum against human osteosarcoma cell lines in vitro. Pediatr Hematol Oncol (1992) 1.41
Low-grade non-Hodgkin's lymphoma after high-grade non-Hodgkin's lymphoma in a child with ataxia telangiectasia. Cancer (1994) 1.40
Basic methods and the developing structure of a late effects surveillance system (LESS) in the long-term follow-up of pediatric cancer patients in Germany. For the German Late Effects Study Group in the German Society Pediatric Oncology and Hematology (GPOH). Med Pediatr Oncol (2000) 1.40
TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood. Berlin-Frankfurt-Münster Study Group. Leukemia (1999) 1.40
Polycyclic aromatic hydrocarbons (PAHs) in agricultural soil and vegetables from Tianjin. Sci Total Environ (2004) 1.36
Primary gastric tuberculosis: a case report and literature review. Am J Gastroenterol (1987) 1.32
Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia. Leukemia (2010) 1.29
Pharmacokinetic properties of the new cephalosporin antibiotic HR 810 in animals. Infection (1984) 1.28
HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum. Arzneimittelforschung (1983) 1.27
Emphysematous cystitis and pyelitis in a diabetic renal transplant recipient. Transplantation (1996) 1.26
Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Am J Dermatopathol (2000) 1.25
[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]. Klin Padiatr (1987) 1.23
Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia. Lancet (2001) 1.21
[The BFM 76/79 acute lymphoblastic leukemia therapy study (author's transl)]. Klin Padiatr (1981) 1.17
Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy. Ann Surg (2001) 1.17
Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia (2001) 1.16
Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation. J Biol Chem (2000) 1.16
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. J Clin Oncol (2001) 1.15
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol (2001) 1.13
Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr Res (2008) 1.13
Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med (1992) 1.10
Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia (2012) 1.10
Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfus (1990) 1.09
[Biomechanics of the external fixation clamps]. Unfallheilkunde (1978) 1.08
Having children after surviving cancer in childhood or adolescence - results of a Berlin survey. Klin Padiatr (2008) 1.07
Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology. Clin Chem (2001) 1.06
Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration. Clin Ther (1987) 1.05
Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice. Pediatr Hematol Oncol (2000) 1.04
Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure. Br J Cancer (2005) 1.04
Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. Cancer Lett (2003) 1.04
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood (1992) 1.02
Identification of the species origin of highly processed meat products by mitochondrial DNA sequences. PCR Methods Appl (1995) 1.02
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF. Leukemia (2004) 1.01
Oral anticoagulation in the treatment of a spontaneously metastasising murine tumour (3LL). Br J Cancer (1977) 1.01
Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin. Antimicrob Agents Chemother (1991) 1.00
Cefodizime, an aminothiazolylcephalosporin. II. Comparative studies on the pharmacokinetic behavior in laboratory animals. J Antibiot (Tokyo) (1984) 1.00
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols. Br J Haematol (2000) 1.00
Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate. Infection (1987) 1.00
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Leukemia (2000) 1.00
Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation (1999) 0.99
Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78. Blood (1985) 0.99
The neutron therapy clinical programme at the National Accelerator Centre (NAC). Bull Cancer Radiother (1996) 0.99
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. Br J Cancer (2003) 0.98
Neonatal lethality in mice deficient in XCE, a novel member of the endothelin-converting enzyme and neutral endopeptidase family. J Biol Chem (1999) 0.98
Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood (1997) 0.98
Cerebral differences in explicit and implicit emotional processing--an fMRI study. Neuropsychobiology (2007) 0.98
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. J Hosp Infect (2012) 0.97
Clinicopathologic features of retinoblastoma after primary chemoreduction. Arch Ophthalmol (1998) 0.97
Development of a homologous expression system for rubber oxygenase RoxA from Xanthomonas sp. J Appl Microbiol (2010) 0.96
Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Ann Oncol (2000) 0.96
Acupuncture to alleviate chemotherapy-induced nausea and vomiting in pediatric oncology - a randomized multicenter crossover pilot trial. Klin Padiatr (2008) 0.95
Preliminary results of primary chemotherapy in retinoblastoma. Klin Padiatr (1997) 0.95
Neutron and neutron-boost irradiation of soft tissue sarcomas: a 4.5 year analysis of 139 patients. Radiother Oncol (1983) 0.93
Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases. Surgery (1999) 0.93
In vitro effect of vegetable and fruit juices on the mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Food Chem Toxicol (1994) 0.92
Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol (1998) 0.92
HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation. Hepatology (1989) 0.91
Biosynthesis of vitamin B12. Transformation of riboflavin 2H-labeled in the 1'R position of 1'S position into 5,6-dimethylbenzimidazole. Eur J Biochem (1992) 0.91
Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation. Eur Arch Psychiatry Clin Neurosci (2006) 0.90
Management of postoperative peritonitis after anterior resection: experience from a referral intensive care unit. Dis Colon Rectum (2000) 0.89